What is Crizalk / XALKORI(crizotinib)
Crizalk / XALKORI(crizotinib)is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in a gene called ALK (anaplastic lymphoma kinase). It is not known if XALKORI is safe and effective in children.
This drug is used to treat advanced non-small cell lung cancers that have a certain mutation in the ALK gene. It is also being studied for use against other types of cancer.
10 X 6S 250mg (60 Tab.)
Storage and handling:
Store at 20° to 25° C, excursions permitted to 15° to 30° C
How do we source the Drug?
SSPWL will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
M/s Pfizer Inc
Call: +91 07738100125 / +91 07738151650 or